EPILOG’s Post

Are you passionate about improving patient outcomes in eye diseases? Do you want to hear directly from patients about their experiences and perspectives? If so, you won't want to miss the upcoming Eyeing Progress Virtual Summit! I am thrilled to announce that our summit will focus on patient-reported outcomes and other critical issues in the field of eye diseases. Whether you are involved in clinical trial design, vision research, or any related industry, this summit is designed to provide you with valuable insights and discussions. REGISTER HERE: https://lnkd.in/gdQjyXmp Join your host Curing Retinal Blindness Foundation (CRB1.org) as we delve into the latest advancements, challenges, and solutions in the realm of eye diseases. From patient testimonials to expert panels, the Eyeing Progress Virtual Summit promises to be a platform for collaboration, learning, and networking. #EyeingProgress #VirtualSummit #PatientOutcomes #EyeDiseases #Innovation #CRB1 #vision #arvo #ClinicalTrial #endpoints #PRO

🧠 Medtech on the Brain 🧠 Vijay Ravindran, founder of autism therapy digital therapeutic firm Floreo, spoke to Medtech Insight about working with the FDA and why the TAP pilot made sense for them: https://ow.ly/nnZV50TgzO1. Medtech Insight is raising awareness for mental health, Alzheimer’s and brain health by speaking with industry leaders about emerging innovations to address neurological diseases and mental health, the regulatory and investment climate, reimbursement, and more. Check out the entire series here: https://ow.ly/eKh450TgzO2.

Today marks the start of the Alzheimer Europe Conference in Geneva. Over the next few days there will be many clinical insights and research highlights discussed. We are ready and set-up at booth number 5. #34AEC #AlzheimersDisease #AlzheimersAwareness

Interested in new frontiers in respiratory clinical trials? 👇 Check out our free on-demand webinar! In this video, Clario's new SVP and Chief AI Officer, Marko Topalovic; Director of Scientific Affairs, Kevin McCarthy; and Senior Director of Respiratory Solutions, Philip Lake, Ph. D., discuss: - Cutting-edge AI-driven approaches to spirometry data analysis, revolutionizing at-home testing with instant feedback and heightened efficacy. - Virtual integration of clinicians into participants' homes, ensuring top-notch data quality and engaging participant experiences. - Remote monitoring of lung sounds and their significant impact on respiratory endpoints within clinical trials. - Explore alternative respiratory endpoints that surpass traditional spirometry, providing greater flexibility and a more comprehensive assessment of lung health. ▶️ Watch now and stay ahead in respiratory research! https://hubs.li/Q02FPVsC0 #spirometry #respiratorycare #clinicaltrials #artificialintelligence

Listening to the lived experiences of those with Alzheimer’s and Parkinson’s isn’t just about understanding—it's about transforming how we develop and deliver care. I’m thrilled to participate in the INTERNATIONAL CONGRESS ON NEURODEGENERATIVE DISEASES, with Alicia Campos from the Federación Española de Parkinson to emphasize the powerful impact of patient voices in shaping Parkinson’s research and treatment. This session will highlight the valuable insights shared by patient associations, leading to a dynamic round table with patients, clinicians, researchers, and associations from Spain and Portugal. Our mission is simple: to ensure that every person affected by neurodegenerative diseases has a say in the research and care that influences their lives. This isn’t just about inclusion; it’s about reshaping the care journey together. Parkinson's Europe

In honour of #ChildhoodCancerAwarenessMonth, today's #CitationSpotlight is the 2017 #ExpertOpinion paper by Ferrari et al. "The challenge of very rare #ChildhoodCancers in developed and developing countries". In the face of #RareDisease such as rare #ChildhoodCancer, cooperation, networking, and research are integral to improving the quality of patient care. Read the complete article: https://lnkd.in/enVSxMab

What a great way to learn more about The Longest Day and the latest Alzheimer's research!

Stroke diagnosis and treatment are complex, with no singular right approach. Each case brings its own nuances, and navigating these differences along the stroke pathway is crucial. However, a universal truth in stroke care is that faster treatment will lead to better patient outcomes. Achieving this often means optimizing the workflow to ensure that every step, from technological integration to process alignment, is seamless. At Hospital Universitari Vall d'Hebron in Barcelona, Dr. Carlos Molina, and Dr. Alejandro Tomasello Weitz, are at the forefront, working on improving the stroke workflow with the help of our solutions. Watch the video to learn about the challenges they face and how they overcome them: https://lnkd.in/dcKiZZzs

Real World Outcomes....for real!! Check out Katie's overview of a recent successful Medscape curriculum that demonstrates statistical significance in increasing the rate of diagnosis for Alzheimer's disease among our learners.

As we wrap up the insightful discussions from the GAP-Net Site Optimization Conference #GAPNet2024 in the vibrant city of New Orleans, we eagerly set our sights on the the AD/PD Conference, poised to kick off tomorrow in Lisbon, Portugal.   But before we delve into the promising avenues awaiting us at #ADPD2024, let's reflect on the highlights of our time at the GAP-Net conference. Our Chief Business Officer, Joe Donahue, discussed the results from our Gemini Alzheimer’s Digital Twins, derived from the GAP Bio-Hermes dataset; showcasing new levels of predictive accuracy of PET positivity across different ethnoracial groups as well as various disease stages. These models may result in a cost-effective and convenient approach to address the high screen failure rate in clinical trial recruitment that currently plagues Alzheimer’s clinical trials.   Now, as we gear up for AD/PD, make sure to connect with our team and learn more on the use of our Gemini Alzheimer’s and Parkinson's Digital Twins.   Here's to pushing boundaries and charting the course towards a brighter tomorrow for AD and PD patients! See you in Lisbon!   #Aitia #ATeam #DigitalTwins #GeminiDigitalTwins #DrugDiscovery #alzheimersdisease #parkinsonsdisease   Global Alzheimer's Platform Foundation, AD/PD - Advances in Science & Therapy, Jerome Windsor, Ruby Hsu